
Ligandrol (LGD-4033)
Ligandrol (LGD-4033, VK5211) is a SARM that was tested in two company trials and never approved. In 76 healthy young men, 1 mg daily for 21 days raised lean body mass by an average of 1.21 kg, without significant gains in strength or stair-climbing power, while lowering testosterone and HDL cholesterol. A 12-week phase 2 trial in 108 older adults after hip fracture posted placebo-adjusted lean mass gains of 4.75% to 9.08% on ClinicalTrials.gov; we found no full published paper of it. Case reports describe severe cholestatic liver injury in people using products sold as ligandrol, and FDA warns that SARMs are linked to liver injury, heart attack and stroke risk, infertility and other harms.
Research compound: not an approved drug or dietary supplement
This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only. Talk to a clinician before considering it.
Quick decision guide
May help most
No approved or proven use; no trial is currently listed as recruiting
Common dosing range
No approved or established dose. Trials gave 0.1 to 1 mg daily for 21 days (healthy young men) and 0.5 to 2 mg daily for 12 weeks (older adults after hip fracture), under medical monitoring
When to expect effects
Lean mass changes were measured after 3 weeks and 12 weeks in trials
Watch out for
Not FDA-approved; FDA says SARMs cannot be legally sold as dietary supplements and has sent warning letters to sellers of LGD-4033, including in December 2025; case reports describe severe liver injury; FDA links SARMs to heart attack and stroke risk, infertility, testicular shrinkage and psychosis; products sold online are often mislabeled; prohibited at all times in sport (WADA 2026 list, S1.2)
What is it
Ligandrol (LGD-4033, later developed as VK5211) is an investigational drug that is not FDA-approved for any use, and FDA says products sold as SARMs cannot be legally marketed in the US as a dietary supplement or a drug. It is a nonsteroidal selective androgen receptor modulator (SARM): a lab-made compound taken by mouth that acts on the same receptor as testosterone. It was developed by Ligand Pharmaceuticals, which funded a 21-day trial in 76 healthy young men published in 2013, and the same compound, coded VK5211, was then tested by Viking Therapeutics in a 12-week phase 2 trial in 108 adults aged 65 and older recovering from hip fracture (completed in 2017). ClinicalTrials.gov lists no other trials of ligandrol, LGD-4033 or VK5211, and no active ones. Products sold online as "Ligandrol" or "LGD-4033", including those labeled "research" products, are not the trial drug: FDA calls them unapproved new drugs, and an independent lab analysis found many products sold as SARMs were mislabeled.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
lean body mass in healthy young men Limited Evidence | Average 1.21 kg more lean mass at 1 mg daily after 21 days | Research participants in controlled trials only | 3 weeks |
muscle strength and stair-climbing power Limited Evidence | No statistically significant change compared with placebo | None established | Not shown |
lean body mass in healthy young men
- Effect
- Average 1.21 kg more lean mass at 1 mg daily after 21 days
- Best fit
- Research participants in controlled trials only
- Time
- 3 weeks
muscle strength and stair-climbing power
- Effect
- No statistically significant change compared with placebo
- Best fit
- None established
- Time
- Not shown
Evidence for 2 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
lean body mass in healthy young men
Biomarker supportIn a placebo-controlled trial funded by Ligand Pharmaceuticals, 76 healthy men aged 21 to 50 (mean age 37, normal testosterone) were randomly assigned to placebo or ligandrol 0.1, 0.3 or 1.0 mg daily for 21 days; 68 completed it. Lean body mass measured by DXA rose with the dose (p for trend = .04), by an average of 1.21 kg at 1.0 mg (p = .047 vs placebo). Fat mass did not change significantly, and the gain in appendicular skeletal muscle mass was not significantly different from placebo. The same trial found dose-dependent falls in total testosterone, SHBG and HDL cholesterol (HDL down 19.4 mg/dL from a baseline of 49.2 at 1.0 mg), which returned to baseline after the drug was stopped. The trial lasted only 3 weeks, included no women and no older or ill people, and did not measure long-term safety or health outcomes.
Bottom line: One 3-week company trial showed a small lean mass gain along with lower testosterone and HDL cholesterol.
muscle strength and stair-climbing power
No benefit foundThe same 21-day trial in 76 healthy men measured leg press strength and stair-climbing speed and power. Leg press strength rose by an average of 68.3 N at the 1.0 mg dose, but this was not significantly different from placebo (p for trend = .203), and stair-climbing speed and power showed only a trend that did not reach statistical significance. The authors noted that the 3-week study was not designed to show maximal effects on muscle mass and strength, which were not its primary outcomes. No longer trial of strength or function has been published.
Bottom line: In the only published trial, ligandrol did not significantly improve strength or stair-climbing power.
How it works
How to take it
What to track
Bottom line: No dose is approved or established, and the products sold online were never tested in trials.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Severe liver injury. Case reports describe cholestatic liver injury in people who used products sold as ligandrol: a 32-year-old man who took it daily for about 2 weeks developed jaundice, itching and about 40 lb of weight loss, with total bilirubin of 35.0 mg/dL and a liver biopsy showing cholestatic hepatitis with mild fibrosis; a 37-year-old man had bilirubin 30 times the upper limit of normal, with loss of bile ducts (ductopenia) and fibrosis on biopsy; a 52-year-old man developed itchy jaundice and weight loss after 3 months of high-dose use; and a 52-year-old man had liver injury after products containing RAD-140 and LGD-4033, with liver tests normal about 3 months after stopping. In most reports the product was not analyzed, so other ingredients cannot be ruled out. FDA lists liver injury and acute liver failure among the serious problems linked to SARMs. The 21-day trial at up to 1 mg did not show significant changes in liver enzymes.
Heart attack and stroke risk, and lower HDL cholesterol. In a 2017 warning letter to a company selling ostarine and LGD-4033, FDA states that SARMs have the potential to increase the risk of heart attack and stroke, and that their long-term safety, including effects on blood lipids, remains unclear. In the 21-day trial, HDL cholesterol fell by 19.4 mg/dL at 1.0 mg daily. In a published case report of a 25-year-old man who used LGD-4033 together with MK-677 for 5 weeks, HDL fell 36.4% and LDL rose 40.0%.
Hormone and fertility effects. In the 21-day trial, total testosterone and SHBG fell with the dose, and free testosterone and FSH fell at 1.0 mg. In the case report of LGD-4033 used with MK-677 for 5 weeks, total testosterone fell 62.3% and FSH stayed below the reference range after stopping. FDA lists infertility, testicular shrinkage, sexual dysfunction and pregnancy miscarriage among the problems that studies and reports associate with SARMs.
Psychiatric, sleep, tendon and muscle effects. FDA lists psychosis or hallucinations and sleep disturbances among serious or life-threatening problems associated with SARMs. A 2023 systematic review of SARM safety in healthy adults found case reports of drug-induced liver injury (15), Achilles tendon rupture (1) and rhabdomyolysis, a severe muscle breakdown (1), across SARMs in general.
Mislabeled and unapproved products. In a 2016 analysis of 44 products sold online as SARMs, only 23 (52%) contained a SARM (ostarine, LGD-4033 or andarine), 17 (39%) contained another unapproved drug, 11 (25%) contained substances not on the label, 4 (9%) contained no active compound, and the amount matched the label in only 18 (41%). In December 2025, FDA issued a warning letter to a seller of "LGD-4033" (ligandrol) capsules marketed as "Research-grade compound[s]", stating that the products are unapproved new drugs intended for human use.
Who should avoid it
- Anyone outside a supervised clinical trial: FDA says SARMs are not approved, have not been reviewed for safety or efficacy, and that consumers should be advised against using them
- Teenagers and young adults, the group FDA says social media sellers and influencers target
- People with liver disease or a history of jaundice: case reports describe severe cholestatic liver injury after ligandrol use
- People with heart disease, risk factors for heart attack or stroke, or low HDL cholesterol
- Athletes tested under anti-doping rules: SARMs have been prohibited at all times since 2008, and the 2026 WADA Prohibited List names LGD-4033 (ligandrol) under S1.2, other anabolic agents
Pregnancy & breastfeeding
There are no human data on ligandrol in pregnancy or breastfeeding; the published trial enrolled only men. FDA lists infertility and pregnancy miscarriage among the problems linked to SARMs. Avoid use if you are pregnant, breastfeeding or trying to conceive, and talk to your doctor.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is ligandrol FDA-approved?⌄
No. Ligandrol (LGD-4033, VK5211) is not approved for any use, and ClinicalTrials.gov lists no active trials of it. FDA states that SARMs are not FDA approved.
Is it legal to buy ligandrol as a supplement or a research chemical?⌄
FDA says SARMs cannot be legally marketed in the US as a dietary supplement or a drug at this time, and that products marketed as supplements or "sold for research use only" are considered unapproved drugs. FDA has sent warning letters to sellers of LGD-4033 since at least 2017, including in December 2025, and says it has also pursued criminal actions against distributors.
What did the ligandrol trials show?⌄
In the published trial, 76 healthy men took placebo or 0.1 to 1 mg daily for 21 days: lean body mass rose by an average of 1.21 kg at 1 mg, strength and stair-climbing power did not improve significantly, and testosterone and HDL cholesterol fell, returning to baseline after stopping. In a phase 2 trial in 108 adults aged 65 and older after hip fracture, results posted on ClinicalTrials.gov show placebo-adjusted gains in lean body mass of 4.75%, 7.15% and 9.08% at 0.5, 1 and 2 mg daily after 12 weeks; serious adverse events occurred in 4 of 28 people on placebo and 2 of 29, 3 of 26 and 5 of 25 on the three doses. We found no full published paper of that trial, and it did not lead to an approval.
Can ligandrol damage the liver?⌄
Case reports describe serious cholestatic liver injury in people who used products sold as ligandrol, in one case after about 2 weeks of daily use, with very high bilirubin and scarring (fibrosis) on liver biopsy. The 21-day trial at up to 1 mg did not show liver enzyme changes, but products sold online are untested and often mislabeled. FDA lists liver injury and acute liver failure among the harms linked to SARMs. Anyone with yellow skin or eyes, dark urine or severe itching should get prompt medical care.
Is ligandrol banned in sport?⌄
Yes. The 2026 WADA Prohibited List names LGD-4033 (ligandrol) as a SARM under S1.2, other anabolic agents, which are prohibited at all times, in and out of competition. Athletes should check the current list with their anti-doping organization.
Can I take ligandrol with my supplements or medicines?⌄
No interaction studies of ligandrol with any medicine or supplement have been published. It lowers HDL cholesterol and testosterone, it builds up in the body with daily use, and products sold online may contain other drugs. Ask a doctor or pharmacist to review your full list, and tell them if you have used ligandrol.
References by claim
lean body mass in healthy young men
Basaria et al., 2013 · PMC (2013) link
Safety
Barbara et al., 2020 · PMC (2020) link
Wallstab et al., 2023 · PubMed (2023) link
Labban et al., 2024 · PMC (2024) link
Barbara et al., 2020 · PMC (2020) link
Adolf et al., 2026 · PubMed (2026) link
FDA Consumer Update: FDA Warns of Use of Selective Androgen Receptor Modulators (SARMs) Among Teens, Young Adults · FDA link
FDA warning letter to Panther Sports Nutrition (October 23, 2017): products labeled to contain ostarine and LGD-4033 · FDA link
Cardaci et al., 2022 · PubMed (2022) link
Vignali et al., 2023 · PMC (2023) link
Van Wagoner et al., 2017 · PMC (2017) link
WADA Prohibited List (current list, S1.2 Other anabolic agents: SARMs, e.g. enobosarm (ostarine), LGD-4033 (ligandrol)) · World Anti-Doping Agency link
Track Ligandrol (LGD-4033) with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research (much of it preclinical or early-stage), not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.
